Cargando…

Current ultrasound-related strategies for assessing liver fibrosis in chronic liver disease

Detalles Bibliográficos
Autores principales:	Xue, Li-Yun, Ding, Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2020
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7725523/ https://www.ncbi.nlm.nih.gov/pubmed/33009023 http://dx.doi.org/10.1097/CM9.0000000000001136

Ejemplares similares

Ultrasound liver elastography beyond liver fibrosis assessment
por: Ferraioli, Giovanna, et al.
Publicado: (2020)

Liver fibrosis and adverse outcomes in COVID-19
por: Huang, Jianmin
Publicado: (2021)

Utility of convolutional neural network-based algorithm in medical images for liver fibrosis assessment
por: Wei, Wei, et al.
Publicado: (2021)

Histological analysis of hypoglycemic agents on liver fibrosis in patients with non-alcoholic fatty liver disease: a systematic review
por: Xie, Qingxing, et al.
Publicado: (2023)

Tetrahydropalmatine attenuates liver fibrosis by suppressing endoplasmic reticulum stress in hepatic stellate cells
por: Xuan, Yuanyuan, et al.
Publicado: (2022)

Reply to: “Liver fibrosis and adverse outcomes in COVID-19”
por: Ruiz-Margáin, Astrid, et al.
Publicado: (2021)

Current Strategies for Quantitating Fibrosis in Liver Biopsy
por: Wang, Yan, et al.
Publicado: (2015)

Transfer learning radiomics based on multimodal ultrasound imaging for staging liver fibrosis
por: Xue, Li-Yun, et al.
Publicado: (2020)

Acute-on-Chronic Liver Failure: Possibly the Main Culprit of Increased Mortality in COVID-19 Patients with Liver Disease
por: Khan, Muhammad Umair, et al.
Publicado: (2021)

Quantitative ultrasound, elastography, and machine learning for assessment of steatosis, inflammation, and fibrosis in chronic liver disease
por: Destrempes, François, et al.
Publicado: (2022)

Insulin Resistance and Genetic Risk Predict Liver‐Related Outcomes and Death in Nonalcoholic Fatty Liver Disease
por: Danford, Christopher J., et al.
Publicado: (2019)

Impact of Preexisting Chronic Liver Disease on the Outcome of Patients With COVID-19 Disease
por: Verma, Nipun, et al.
Publicado: (2021)

Commentary on “Simple non-invasive biomarkers of advanced fibrosis in the evaluation of non-alcoholic fatty liver disease”
por: Kayadibi, Huseyin, et al.
Publicado: (2014)

Improving detection of cystic fibrosis related liver disease using liver fibrosis assessment tools()
por: Scott, Jennifer A., et al.
Publicado: (2023)

Current Treatment Options for Cystic Fibrosis-Related Liver Disease
por: Staufer, Katharina
Publicado: (2020)

Ultrasound Evaluation of Liver Fibrosis
por: Lin, Yang-Sheng
Publicado: (2017)

Nomogram for predicting advanced liver fibrosis and cirrhosis in patients with chronic liver disease
por: Ding, Rongrong, et al.
Publicado: (2021)

Ultrasound in chronic liver disease
por: Gerstenmaier, J. F., et al.
Publicado: (2014)

Predictive performance of eLIFT for liver inflammation and fibrosis in chronic liver diseases
por: Yang, Zongguo, et al.
Publicado: (2021)

Is aspartate aminotransferase-to-platelet ratio index a biomarker in the evaluation of advanced fibrosis in non-alcoholic fatty liver disease?
por: Agilli, Mehmet, et al.
Publicado: (2014)

Current Modalities of Fibrosis Assessment in Non-alcoholic Fatty Liver Disease
por: Cheah, Mark CC, et al.
Publicado: (2017)

Comparison of portal vein hemodynamics with ultrasound-based elastography for the prediction of liver fibrosis in patients with chronic liver disease
por: Yamaguchi, Kanji, et al.
Publicado: (2023)

Cost-effectiveness of enhanced liver fibrosis test to assess liver fibrosis in chronic hepatitis C virus and alcoholic liver disease patients
por: Soto, Marcelo, et al.
Publicado: (2017)

Collaboration Is Needed to Translate Pharmacology Data Into Better Health Outcomes in Chronic Liver Disease
por: Weersink, Rianne A., et al.
Publicado: (2021)

No association of serum ferritin levels with advanced liver fibrosis in untreated German patients with autoimmune hepatitis
por: Engel, Bastian, et al.
Publicado: (2022)

Enzymes of Fibrosis in Chronic Liver Disease
por: Tsomidis, Ioannis, et al.
Publicado: (2022)

Combination of FIB-4 with ultrasound surface nodularity or elastography as predictors of histologic advanced liver fibrosis in chronic liver disease
por: Moini, Maryam, et al.
Publicado: (2021)

Liver transplantation for hypoparathyroidism secondary to Wilson's disease
por: Zhang, Zhi-Bin, et al.
Publicado: (2019)

Usefulness of Enhanced Liver Fibrosis, Glycosylation Isomer of Mac-2 Binding Protein, Galectin-3, and Soluble Suppression of Tumorigenicity 2 for Assessing Liver Fibrosis in Chronic Liver Diseases
por: Moon, Hee-Won, et al.
Publicado: (2018)

Endoscopic ultrasound in chronic liver disease
por: Fung, Brian M, et al.
Publicado: (2020)

Assessment of liver fibrosis by ultrasound elastography and contrast-enhanced ultrasound: a randomized prospective animal study
por: Qiu, Tingting, et al.
Publicado: (2017)

Targeted liver ultrasound for chronic liver disease: time to focus?
por: Gibson, Robert N
Publicado: (2015)

Joint Efforts to Ensure Evidence‐Based Decisions by Clinicians in Drug Adjustment for Chronic Liver Disease Populations
por: Ferreira, Victor, et al.
Publicado: (2021)

Correspondence on Editorial regarding “Impact of nationwide hepatocellular carcinoma surveillance on the prognosis in patients with chronic liver disease”
por: Sohn, Won, et al.
Publicado: (2023)

4267 Noninvasive hybrid ultrasound and photoacoustic imaging for the assessment of liver fibrosis
por: Sultan, Laith Riyadh, et al.
Publicado: (2020)

Non-invasive assessment of liver fibrosis in alcoholic liver disease
por: Husain, Ayan, et al.
Publicado: (2020)

Noninvasive assessment of liver fibrosis with the aspartate transaminase to platelet ratio index (APRI): Usefulness in patients with chronic liver disease: APRI in chronic liver disease
por: Yilmaz, Yusuf, et al.
Publicado: (2011)

Assessing Influences of Perioperative Transfusion on Early- and Late-Term Outcomes after Living Donor Liver Transplantation: Methodological Issues
por: Xue, Fu-Shan, et al.
Publicado: (2018)

Molecular characterization of chronic liver disease dynamics: From liver fibrosis to acute-on-chronic liver failure
por: Graupera, Isabel, et al.
Publicado: (2022)

Is the aspartate transaminase to platelet ratio index adequate for the assessment of liver fibrosis in patients with chronic liver disease?
por: Parsian, Hadi
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_pckk4kmlhj8d5fnl5ts9ocicvn